drugset / Trial / NCT00003654

Diagnostic Study to Identify Sentinel Lymph Nodes in Women With Stage I or Stage II Breast Cancer

NCT00003654 ↗

Terminated 200 enrolled UNICANCER
Diagnostic

Summary

RATIONALE: Diagnostic procedures, such as blue dye or imaging to identify sentinel lymph nodes, may improve the ability to detect the extent of disease and help plan effective surgery for removing breast tumors. PURPOSE: Diagnostic trial to study the effectiveness of blue dye and an imaging procedure to identify the sentinel lymph node under the arm in women with stage I or stage II breast cancer.

Timeline

Start
1997-09
Primary completion
2000-01
Completion
2000-01

Drugs

EvaluationDrugModalityDoseRoute
Subject patent blue V dye Diagnostic / imaging agent — Other

Indications